Food and Drug Administration
Allergenic Products Advisory Committee
March 15, 2002
Slides
COMMITTEE
UPDATES (Open Session)
Overview of the Division of Bacterial, Parasitic & Allergenic Products (DBPAP), Richard Walker, Ph.D., Division Director, FDA ppt htm
Overview of the
Laboratory of Immunobiochemistry: Personnel, organizational, and lot release activities,
Jay E. Slater, M.D., DBPAP, Laboratory Chief
LIB
Site Visit, January 24, 2002, Jay E. Slater, M.D., DBPAP, Laboratory Chief
Particulates in Allergen Extracts and Compliance Overview, Jay E. Slater, M.D., FDA ppt htm
Compliance Update, Teddi Lopez, OCBQ, FDA ppt htm
Reduction of Possible Exposure to TSE Agents in Allergen Extracts, Jay
E. Slater, M.D., FDA ppt
htm
Open Public Hearing
REGULATORY DISCUSSION TOPICS (Open Session)
Considerations for the Regulation of Recombinant Allergens for the Diagnosis and Treatment of Allergic Disease, Jay E. Slater, M.D., FDA ppt htm
Glycerol in Allergen Extracts, Jay E. Slater, M.D., FDA ppt htm